Clinical Trial Update: Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK) [Phase 3]

View source ↗

Summary

Phase 3 trial reporting non-inferiority of PRO-122 ophthalmic solution compared to KRYTANTEK Ofteno in primary open-angle glaucoma and ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Krytantek Ofteno
• PRO-122 ophthalmic solution

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2019-12-09